Literature DB >> 3788423

Immunoextracted calcitonin in milk and plasma from totally thyroidectomized women. Evidence of monomeric calcitonin in plasma during pregnancy and lactation.

E Bucht, M Telenius-Berg, G Lundell, H E Sjöberg.   

Abstract

The level of immunoreactive calcitonin in the first produced breast milk was in totally thyroidectomized (TX) women 713 +/- 307 pg-eq/ml (mean +/- SD, N = 7) and in control women 772 +/- 329 pg-eq/ml (N = 33), i.e. about 45 times higher than in plasma (see below). On gel chromatography of immunoextracted milk from TX women, immunoreactive calcitonin appeared as high molecular weight forms in the same pattern as in milk from healthy women when the same antiserum was used for immunoextraction and radioimmunoassay (RIA). In another series of experiments, a new antiserum raised in rabbits was used for measurement of immunoreactive calcitonin after immunoextraction with 1. Plasma levels of immunoreactive calcitonin in the TX women during pregnancy were 16 +/- 6 pg-eq/ml (N = 6) and during lactation 14 +/- 7 pg-eq/ml (N = 5). Immunoreactive calcitonin was undetectable (less than 8 pg/ml) in plasma from those TX women in whom lactation had stopped (N = 5). Immunoextraction and gel chromatography of plasma collected during pregnancy and lactation from the TX women showed that the immunoreactive calcitonin present eluted in the region of monomeric calcitonin with both antiserum 1 and 2. In conclusion, high concentrations of high molecular weight forms of of immunoreactive calcitonin have been demonstrated in milk from TX patients, most probably devoid of any calcitonin-producing thyroid C-cells. This points to a local production site in the mammary gland.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3788423     DOI: 10.1530/acta.0.1130529

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  8 in total

1.  Circulating monomer-like calcitonin in osteoporotic patients.

Authors:  H Rong; M Sääf; O Tørring; U Sjöstedt; E Bucht
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

Review 2.  Presentation and management of osteoporosis presenting in association with pregnancy or lactation.

Authors:  C S Kovacs; S H Ralston
Journal:  Osteoporos Int       Date:  2015-05-05       Impact factor: 4.507

Review 3.  Morphological, hormonal, and molecular changes in different maternal tissues during lactation and post-lactation.

Authors:  Gustavo Canul-Medina; Cristina Fernandez-Mejia
Journal:  J Physiol Sci       Date:  2019-09-28       Impact factor: 2.781

Review 4.  Calcium and vitamin D metabolism during lactation.

Authors:  R L Horst; J P Goff; T A Reinhardt
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-07       Impact factor: 2.673

5.  Severe postpartum osteoporosis with increased PTHrP during lactation in a patient after total thyroidectomy and parathyroidectomy.

Authors:  E Segal; I Hochberg; Y Weisman; S Ish-Shalom
Journal:  Osteoporos Int       Date:  2011-01-18       Impact factor: 4.507

6.  Serum calcitonin forms and concentrations in young and elderly healthy females.

Authors:  E Bucht; H Rong; H E Sjöberg; U Sjöstedt; B Granberg; O Tørring
Journal:  Calcif Tissue Int       Date:  1995-01       Impact factor: 4.333

Review 7.  Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus.

Authors:  Aliya A Khan; Christian A Koch; Stan Van Uum; Jean Patrice Baillargeon; Jens Bollerslev; Maria Luisa Brandi; Claudio Marcocci; Lars Rejnmark; Rene Rizzoli; M Zakarea Shrayyef; Rajesh Thakker; Bulent O Yildiz; Bart Clarke
Journal:  Eur J Endocrinol       Date:  2019-03       Impact factor: 6.664

Review 8.  Hypoparathyroidism in Pregnancy and Lactation: Current Approach to Diagnosis and Management.

Authors:  Dalal S Ali; Karel Dandurand; Aliya A Khan
Journal:  J Clin Med       Date:  2021-03-29       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.